Status:
COMPLETED
Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis
Lead Sponsor:
German Cancer Research Center
Conditions:
Breast Cancer
Breast Cancer Mortality
Eligibility:
FEMALE
50-74 years
Brief Summary
The MARIEplus study is a prospective cohort of breast cancer patients recruited into the MARIE (Mamma Carcinoma Risk factor InvEstigation) study, a population-based case-control study of breast cancer...
Eligibility Criteria
Inclusion
- Histologically confirmed Primary invasive (ICD-10 C50) (stage I-IV) or in-situ (ICD-10 D05) breast cancer
- 50 to 74 years at diagnosis
- Patients in the city and state of Hamburg in northern Germany and the Rhine-Neckar-Karlsruhe region in southern Germany
- German-speaking
- Physically and mentally ability to participate in a personal interview of about 90 minutes
Exclusion
- Previous diagnosis of breast cancer
Key Trial Info
Start Date :
August 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2015
Estimated Enrollment :
3813 Patients enrolled
Trial Details
Trial ID
NCT03401034
Start Date
August 1 2002
End Date
June 30 2015
Last Update
January 17 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.